BIOTECH

BIOTECH

Cilcare completes a €40M series A

The funds will support two Phase 2a clinical trials for the drug candidate CIL001, targeting...

Read more

BIOTECH

Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies

CHAPEL HILL, NC / ACCESSWIRE / November 25, 2024 / Doron Therapeutics, a clinical-stage biotech company...

Read more

BIOTECH

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”

Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar’s novel oral plant-based...

Read more

BIOTECH

ObvioHealth Welcomes Richard Watkins as Chief Revenue Officer at a Pivotal Moment of Transformation

Experienced Sales Leader to Drive Revenue Growth as ObvioHealth Transitions to Enterprise Solutions NEW YORK, Oct....

Read more

BIOTECH

PulseSight Therapeutics to Present Data on PST-611 at EVER Congress 2024

PARIS, Oct. 07, 2024 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing...

Read more